Table 1. The association of miRNA-339 expression levels with clinical pathology features in GC.
| Characteristics | Number (n=46) | miRNA-339 | P value | |
|---|---|---|---|---|
| Low (n=31) | High (n=15) | |||
| Age (years) | 0.204 | |||
| ≤60 | 26 | 20 | 6 | |
| >60 | 20 | 11 | 9 | |
| Gender | 0.539 | |||
| Male | 24 | 15 | 9 | |
| Female | 22 | 16 | 6 | |
| Tumor size (cm) | 0.058 | |||
| ≤3 cm | 15 | 10 | 5 | |
| >3 cm | 31 | 21 | 10 | |
| Lymph node metastasis | 0.008* | |||
| Yes | 29 | 24 | 5 | |
| No | 17 | 7 | 10 | |
| Differentiation | 0.195 | |||
| Well and moderate | 16 | 13 | 3 | |
| Poor | 30 | 18 | 12 | |
| TNM stage | 0.048* | |||
| I and II | 17 | 8 | 9 | |
| III and IV | 29 | 23 | 6 | |
The chi-square test was used for the association analysis and *P<0.05 was considered statistically significant. GC, gastric cancer; TNM, tumor, node, metastasis.